Dipal Doshi is the founder of Entrada Therapeutics. Entrada Therapeutics has raised $241M in total funding. Latest round: Series A. Based in Boston, MA.
Dipal Doshi is the Chief Executive Officer of Entrada Therapeutics, a biotechnology company developing genetic medicines. He was appointed to the board of directors of āshibio, a clinical-stage biotechnology company, in September 2024. Entrada Therapeutics was incubated within 5AM Ventures' 4:59 Initiative.
Full founder directory · Investor directory · Company funding database · Fundraising library